Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19,331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, McCracken M, Mulvey MR, Johnson J; Canadian Antimicrobial Resistance Alliance (CARA); Hoban DJ. Zhanel GG, et al. Among authors: johnson j. Antimicrob Agents Chemother. 2008 Apr;52(4):1430-7. doi: 10.1128/AAC.01538-07. Epub 2008 Feb 19. Antimicrob Agents Chemother. 2008. PMID: 18285482 Free PMC article.
Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ; NAUTICA Group. Zhanel GG, et al. Among authors: johnson j. Int J Antimicrob Agents. 2005 Nov;26(5):380-8. doi: 10.1016/j.ijantimicag.2005.08.003. Int J Antimicrob Agents. 2005. PMID: 16243229
Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Weshnoweski B, Johnson J, Noreddin A, Low DE, Karlowsky JA; NAUTICA Group; Hoban DJ. Zhanel GG, et al. Among authors: johnson j. Int J Antimicrob Agents. 2006 Jun;27(6):468-75. doi: 10.1016/j.ijantimicag.2006.02.009. Epub 2006 May 18. Int J Antimicrob Agents. 2006. PMID: 16713191
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).
Zhanel GG, DeCorby M, Adam H, Mulvey MR, McCracken M, Lagacé-Wiens P, Nichol KA, Wierzbowski A, Baudry PJ, Tailor F, Karlowsky JA, Walkty A, Schweizer F, Johnson J; Canadian Antimicrobial Resistance Alliance; Hoban DJ. Zhanel GG, et al. Among authors: johnson j. Antimicrob Agents Chemother. 2010 Nov;54(11):4684-93. doi: 10.1128/AAC.00469-10. Epub 2010 Aug 30. Antimicrob Agents Chemother. 2010. PMID: 20805395 Free PMC article.
Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Hisanaga T, Johnson JL, Hoban DJ; NAVRESS Group. Zhanel GG, et al. Among authors: johnson jl. J Antimicrob Chemother. 2003 Sep;52(3):382-8. doi: 10.1093/jac/dkg352. Epub 2003 Jul 29. J Antimicrob Chemother. 2003. PMID: 12888592
A comparative In vitro surveillance study of gemifloxacin activities against 2,632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America. The Gemifloxacin Surveillance Study Research Group.
Hoban DJ, Bouchillon SK, Karlowsky JA, Johnson JL, Butler DL, Miller LA, Poupard JA. Hoban DJ, et al. Among authors: johnson jl. Antimicrob Agents Chemother. 2000 Nov;44(11):3008-11. doi: 10.1128/AAC.44.11.3008-3011.2000. Antimicrob Agents Chemother. 2000. PMID: 11036014 Free PMC article.
Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study.
Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Saunders KA, Miller LA, Poupard JA; Surveillance Study Research Group. Hoban DJ, et al. Among authors: johnson jl. Int J Antimicrob Agents. 2003 May;21(5):425-33. doi: 10.1016/s0924-8579(03)00038-4. Int J Antimicrob Agents. 2003. PMID: 12727075
In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study.
Bouchillon SK, Hoban DJ, Johnson JL, Johnson BM, Butler DL, Saunders KA, Miller LA, Poupard JA. Bouchillon SK, et al. Among authors: johnson jl, johnson bm. Int J Antimicrob Agents. 2004 Feb;23(2):181-96. doi: 10.1016/j.ijantimicag.2003.08.006. Int J Antimicrob Agents. 2004. PMID: 15013045
19,331 results
You have reached the last available page of results. Please see the User Guide for more information.